BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 6178438)

  • 21. Reaction of alpha 2-macroglobulin with plasmin increases binding of transforming growth factors-beta 1 and beta 2.
    LaMarre J; Wollenberg GK; Gonias SL; Hayes MA
    Biochim Biophys Acta; 1991 Jan; 1091(2):197-204. PubMed ID: 1704799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of tumor necrosis factor alpha to activated forms of human plasma alpha 2 macroglobulin.
    Wollenberg GK; LaMarre J; Rosendal S; Gonias SL; Hayes MA
    Am J Pathol; 1991 Feb; 138(2):265-72. PubMed ID: 1704186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in trypsin-binding properties and conformation of rabbit alpha-2-macroglobulin on reaction with methylamine.
    Tamamizu S; Miyake Y; Ito T; Sinohara H
    J Biochem; 1989 Jun; 105(6):898-904. PubMed ID: 2475483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human activated Factor X by antithrombin III and alpha 1-proteinase inhibitor in human plasma.
    Gitel SN; Medina VM; Wessler S
    J Biol Chem; 1984 Jun; 259(11):6890-5. PubMed ID: 6202686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical properties of human alpha 2-macroglobulin following reaction with methylamine and trypsin.
    Gonias SL; Reynolds JA; Pizzo SV
    Biochim Biophys Acta; 1982 Aug; 705(3):306-14. PubMed ID: 6181812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteolytic activity of alpha 2-macroglobulin-enzyme complexes toward human factor VIII/von Willebrand factor.
    Switzer ME; Gordon HJ; McKee PA
    Biochemistry; 1983 Mar; 22(6):1437-44. PubMed ID: 6188490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The conformational changes of alpha 2-macroglobulin induced by methylamine or trypsin. Characterization by extrinsic and intrinsic spectroscopic probes.
    Larsson LJ; Lindahl P; Hallén-Sandgren C; Björk I
    Biochem J; 1987 Apr; 243(1):47-54. PubMed ID: 2440424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo clearance of ternary complexes of vitronectin-thrombin-antithrombin is mediated by hepatic heparan sulfate proteoglycans.
    Wells MJ; Blajchman MA
    J Biol Chem; 1998 Sep; 273(36):23440-7. PubMed ID: 9722580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.
    Gonias SL; Einarsson M; Pizzo SV
    J Clin Invest; 1982 Aug; 70(2):412-23. PubMed ID: 6178757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of alpha1-antitrypsin and alpha-macroglobulins in the uptake of proteinase by rabbit alveolar macrophages.
    Dolovich J; Debanne MT; Bell R
    Am Rev Respir Dis; 1975 Oct; 112(4):521-5. PubMed ID: 54012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hamster alpha-macroglobulin and murinoglobulin: comparison of chemical and biological properties with homologs from other mammals.
    Miyake Y; Shinomura M; Ito T; Yamamoto K; Abe K; Amemiya S; Sinohara H
    J Biochem; 1993 Oct; 114(4):513-21. PubMed ID: 7506251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respective roles of antithrombin III and alpha 2 macroglobulin in thrombin inactivation.
    Fischer AM; Tapon-Bretaudiere J; Bros A; Josso F
    Thromb Haemost; 1981 Feb; 45(1):51-4. PubMed ID: 6166063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chloroquine and primary amines inhibit the internalization of antithrombin III.trypsin complex in cultured cells.
    Savion N; Farzame N
    Thromb Res; 1985 Sep; 39(6):671-82. PubMed ID: 3909504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a monoclonal antibody specific for a neoantigenic determinant on alpha 2-macroglobulin: use for the purification and characterization of binary proteinase-inhibitor complexes.
    Strickland DK; Steiner JP; Migliorini M; Battey FD
    Biochemistry; 1988 Mar; 27(5):1458-66. PubMed ID: 2452653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A study of antithrombin systems during heparin therapy].
    Boneu B; Immaculato F; Sie P; Caranobe C; Chamontin B; Guittard J
    Nouv Presse Med; 1982 Oct; 11(41):3043-6. PubMed ID: 6183640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro preparation of nonenzymatically glucosylated human transferrin, alpha 2-macroglobulin, and fibrinogen with preservation of function.
    Ney KA; Pasqua JJ; Colley KJ; Guthrow CE; Pizzo SV
    Diabetes; 1985 May; 34(5):462-70. PubMed ID: 2580749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of inflammatory proteinase, medullasin, by alpha 2-macroglobulin and ovomacroglobulin.
    Ikai A; Nakashima M; Aoki Y
    Biochem Biophys Res Commun; 1989 Feb; 158(3):831-6. PubMed ID: 2465765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clearance and binding of two electrophoretic "fast" forms of human alpha 2-macroglobulin.
    Imber MJ; Pizzo SV
    J Biol Chem; 1981 Aug; 256(15):8134-9. PubMed ID: 6167573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding and endocytosis of alpha 2-macroglobulin-plasmin complexes.
    Ney KA; Gidwitz S; Pizzo SV
    Biochemistry; 1985 Aug; 24(17):4586-92. PubMed ID: 2415157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A solid-phase immunosorbent assay to determine the proteinase binding capacity of alpha 2-macroglobulin using 125I-trypsin as indicator proteinase.
    Borth W
    Biochim Biophys Acta; 1985 Mar; 838(3):361-9. PubMed ID: 2578825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.